Alto Neuroscience announces Michael Hanley as COO

Alto Neuroscience announced the expansion of the company’s leadership team with the addition of industry veteran Michael Hanley as chief operating officer COO . Mr. Hanley brings over twenty-five years of leadership experience in the life sciences industry, with established expertise across corporate operations, product development, strategy, and commercialization, with relevant expertise in CNS/neuroscience-focused companies. As Alto’s COO, Mike will be responsible for new product planning, portfolio strategy, and cross-functional leadership to maximize the impact of the Company’s clinical-stage programs and biomarker platform.